⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6537023 | 0.69 | — | — | |
| SCHEMBL6537226 | 0.69 | — | — | |
| SCHEMBL15751001 | 0.69 | — | — | |
| SCHEMBL1685338 | 0.67 | — | — | |
| SCHEMBL6471512 | 0.65 | — | — | |
| SCHEMBL1149434 | 0.65 | — | — | |
| SCHEMBL5346918 | 0.65 | — | — | |
| SCHEMBL617774 | 0.63 | — | — | |
| Water SCHEMBL28674918 | 0.63 | — | — | |
| SCHEMBL2497209 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9982029-B2 | Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists | SANOFI (FR) | 2018-05-29 | — | — | US | claimed |
| US-9937230-B2 | Ophthalmic uses of toxin-based therapeutic peptides and pharmaceutical compositions thereof | KINETA ONE, LLC (US) | 2018-04-10 | — | — | US | claimed |
| EP-3263123-A2 | SHK-BASED PHARMACEUTICAL COMPOSITIONS AND METHODS OF MANUFACTURING AND USING THE SAME | Kineta One, LLC (US) | 2018-01-03 | — | — | EP | claimed |
| US-20170274047-A1 | ANALOGS OF SHK TOXIN AND THEIR USES IN SELECTIVE INHIBITION OF KV1. 3 POTASSIUM CHANNELS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-09-28 | — | — | US | claimed |
| EP-2474316-B1 | ANALOGS OF SHK TOXIN AND THEIR USES IN SELECTIVE INHIBITION OF KV1.3 POTASSIUM CHANNELS | UNIV CALIFORNIA (US) | 2016-04-06 | — | — | EP | claimed |
| US-20160000869-A1 | METHODS OF TREATING IPEX SYNDROME USING TOXIN-BASED PHARMACEUTICAL COMPOSITIONS | KINETA ONE, LLC | 2016-01-07 | — | — | US | claimed |
| EP-2717899-A2 | SHK-BASED PHARMACEUTICAL COMPOSITIONS AND METHODS OF MANUFACTURING AND USING THE SAME | Kineta One, LLC (US) | 2014-04-16 | — | — | EP | claimed |
| WO-2012170392-A2 | SHK-BASED PHARMACEUTICAL COMPOSITIONS AND METHODS OF MANUFACTURING AND USING THE SAME | KINETA ONE, LLC (US) | 2012-12-13 | — | — | WO | claimed |
| EP-2474316-A1 | Analogs of SHK toxin and their uses in selective inhibition of KV1.3 potassium channels | The Regents of the University of California (US) | 2012-07-11 | — | — | EP | claimed |
| US-20120142600-A1 | Analogs of ShK Toxin and their Uses in Selective Inhibition of Kv1.3 Potassium Channels | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-06-07 | — | — | US | claimed |
| US-20080221024-A1 | Analogs of Shk Toxin and Their Uses in Selective Inhibittion of Kv1. 3 Potassium Channels | BACHEM AMERICAS, INC. | 2008-09-11 | — | — | US | claimed |
| EP-1796709-A2 | ANALOGS OF SHK TOXIN AND THEIR USES IN SELECTIVE INHIBITION OF KV1.3 POTASSIUM CHANNELS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-06-20 | — | — | EP | claimed |
| WO-2006042151-A2 | ANALOGS OF SHK TOXIN AND THEIR USES IN SELECTIVE INHIBITION OF KV1.3 POTASSIUM CHANNELS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-04-20 | — | — | WO | claimed |
| US-20240077475-A1 | PROTEASE-ACTIVATED CONTRAST AGENTS FOR IN VIVO IMAGING | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-03-07 | — | — | US | disclosed |
| US-20240025945-A1 | PROTEASE-ACTIVATED CONTRAST AGENTS FOR IN VIVO IMAGING | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-01-25 | — | — | US | disclosed |
| US-20240002440-A1 | AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS | JPMORGAN CHASE BANK, N.A. | 2024-01-04 | — | — | US | disclosed |
| EP-1853321-A2 | INSULINOTROPIC AGENTS CONJUGATED WITH STRUCTURALLY WELL DEFINED BRANCHED POLYMERS | NOVO NORDISK A/S (DK) | 2007-11-14 | — | — | EP | disclosed |
| EP-1796709-A2 | ANALOGS OF SHK TOXIN AND THEIR USES IN SELECTIVE INHIBITION OF KV1.3 POTASSIUM CHANNELS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-06-20 | — | — | EP | disclosed |
| WO-2006087354-A2 | INSULINOTROPIC AGENTS CONJUGATED WITH STRUCTURALLY WELL DEFINED BRANCHED POLYMERS | NOVO NORDISK A/S (DK) | 2006-08-24 | — | — | WO | disclosed |
| WO-2006042151-A2 | ANALOGS OF SHK TOXIN AND THEIR USES IN SELECTIVE INHIBITION OF KV1.3 POTASSIUM CHANNELS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-04-20 | — | — | WO | disclosed |